Conventional treatment of saphenous vein reflux by surgical ligation or stripping leads to appreciable trauma, disruption of activities, scarring and high late recurrence rates.1 Alternative, non-surgical techniques are gaining increasing acceptance. Endovenous laser therapy (EVLT) provides a percutaneous technique to destroy larger diameter saphenous veins as an outpatient procedure under local anaesthesia, with minimal disruption of activities and no surgical trauma.2-5 In this article, we describe our early results for 404 saphenous veins in 308 patients treated by EVLT and followed up by ultrasound surveillance.
Two of us who are surgeons used essentially identical techniques for EVLT. The procedure was introduced in January 2002 by K M and adopted in November 2002 by R F, and follow-up for analysis continued until August 2005. Median times for each surgeon’s experience were 31 months for K M and 22 months for R F.
EVLT was offered to patients where preliminary ultrasound scanning showed great or small saphenous reflux with a straight section of saphenous vein of diameter greater than 5–6 mm (30% of all patients referred with varicose veins). Most of the remainder were treated by ultrasound-guided sclerotherapy, as few patients elected to be treated by surgery.
The clinical, aetiological, anatomical, and pathophysiological (CEAP) classification was used to assess the limbs.6 There were 361 limbs with uncomplicated varicose veins (C2–3, 91%) and 35 limbs with complications (C4–6), due to lipodermatosclerosis (n = 26), healed past venous ulceration (n = 6) or active ulceration (n = 3). Primary disease was present in all limbs, and none had features of the post-thrombotic syndrome. There was persistent or recurrent reflux after past saphenous vein surgery by other surgeons in 20 limbs (15 for great saphenous and 5 for small saphenous disease).
Duplex scanning performed by specialist vascular sonographers linked to the surgical units was used to select saphenous veins suitable for EVLT. Limbs were evaluated to detect superficial, deep and perforator reflux, mark the site and extent of disease, and measure the length and diameters of refluxing saphenous veins as previously described.7 All limbs treated had reflux through the corresponding saphenous junction or other major connections to deep veins. The lengths of veins treated ranged from 5 to 55 cm (median, 34 cm) and their diameters from 5 to 20 mm (median, 8 mm).
EVLT was performed using the Diomed 810 nm diode system (Diomed, Inc, Andover, Mass, USA). It is not necessary to sedate the patient. Ultrasound guides the various stages using a 12–5 MHz linear array probe for most limbs. The distal end of the saphenous vein to be treated and the saphenofemoral or saphenopopliteal junction are marked. The limb is prepared as for a surgical operation and the operator is gowned and gloved.
It is essential to repeat the ultrasound scan at 3–5 days after the procedure to confirm that the treated vein has been occluded, determine residual veins to be treated, and exclude deep vein thrombosis. It is then desirable to repeat the scan at 6 weeks, then 6-monthly for 2 years, then annually, looking for occlusion or obliteration, or for recanalisation of the vein.
Follow-up with serial ultrasound scans at the above intervals was used for survival analysis.8 Success was defined as continuing occlusion or obliteration without reflux in any segment of treated vein, as determined by ultrasound.
Univariate Kaplan–Meier life table analysis was used to calculate primary and secondary ultrasound success and failure rates.8 The time to failure was the difference between the date of EVLT and the date that recurrent reflux was demonstrated at follow-up scans. All patients presented for the first post-procedure scan at day 3–7; if failure was noted at this scan, then this was used as the failure date for survival analysis, although it is probable that the procedure had failed from the time it was performed. If a patient noted to have recurrent saphenous reflux had missed a previous scheduled visit, then failure due to recurrent saphenous reflux was dated back to the time of that missed visit.
Initial technical success was achieved in 401 of 404 procedures. In one limb treated for small saphenous reflux, the guidewire and then the laser probe passed up outside the vein without this being recognised until after the procedure. In two other limbs treated for great saphenous reflux, it was considered that a large vein had not been adequately compressed onto the laser probe to achieve occlusion.
In 21 limbs, recanalisation was detected on surveillance, usually to a minor degree when compared with the initial reflux. This resulted in a primary ultrasound success rate at 3 years by life table analysis of 80% (95% CI, 69%–87%) (Box 1A). Eleven of these limbs were treated by ultrasound-guided sclerotherapy to obliterate the recurrent vein at intervals from 7 to 570 days after EVLT, and this was successful in all but one, resulting in a secondary ultrasound success rate at 3 years by life table analysis of 88% (95%,CI, 78%–95%) (Box 1B).
We found that a single episode of EVLT effectively controlled saphenous vein reflux in 80% of veins. EVLT is equally suited to young patients requiring the best cosmetic outcome and elderly patients with complications who might be high risk for surgery. Perivenous anaesthesia allows veins of any diameter or length to be treated by EVLT, but it is probably necessary to ensure that large diameter veins are adequately compressed.
Thromboembolic complications can occur with any treatment for varicose veins. In this series, EVLT had a 2.2% incidence of thromboembolic complications. Van Rij and colleagues documented deep vein thrombosis in 5.3% of limbs after varicose vein surgery, although most were localised to the tibial veins.9
EVLT damages a blood-filled vessel by steam formation, leading to endothelial denudation, collagen contraction and vein wall fibrosis,10-13 and in many limbs the vein is no longer visible at the 6–12 month scans. Our results are similar to those in another large series.2 Other studies have reported satisfactory results for the great saphenous3,4 and small saphenous veins.5
An alternative technique using thermal ablation from a radiofrequency probe has also produced good results with low complication rates.14-17 Ultrasound surveillance shows occlusion of most saphenous veins and infrequent development of new veins in the groin with this technique.16 Randomised trials of radiofrequency closure versus surgery found significantly less postoperative pain, faster rehabilitation, lower cost and persisting better quality of life, as well as similar control of the veins.14-17
Outcomes are satisfactory for treatment of saphenous reflux by ultrasound-guided sclerotherapy,18-20 but there is insufficient information to determine the efficacy of ultrasound-guided sclerotherapy for larger saphenous veins.
Ultrasound surveillance detects a high incidence of failure after surgery for varicose veins.1 Van Rij and colleagues found 25% recurrence after great saphenous surgery and 50% recurrence after small saphenous surgery at 3 years.21 A Swedish study of outcome 10 years after great saphenous ligation and stripping found that 86 of 100 limbs had recurrence involving segments of the great saphenous veins.22 Ultrasound studies after small saphenous surgery found that only 39% of 59 operations were successful at early follow-up in a British report,23 and 5 of 28 operations were successful at 3 months in a Dutch study.24 A British review suggests that this may be due to reluctance to strip the small saphenous vein because of fear of nerve injury.25
There is a high incidence of reconnection from the common femoral vein or low abdominal or pelvic veins to thigh tributaries after surgery, due to opening of pre-existing veins.26,27 Traditional teaching is to ligate all tributaries at the saphenofemoral junction, but there is growing concern that this might predispose to reconnections into thigh veins rather than normal drainage through the saphenous junction. Endovenous techniques are not associated with a high incidence of recurrence in the groin,28 suggesting that leaving tributaries from above the groin may be an advantage.
1 Kaplan–Meier life table analysis of success rates after endovenous laser therapy for all veins treated

A: Primary success rates. B: Secondary success rates. The numbers along the lower axis represent the numbers of veins available for analysis at intervals through the study. Thin lines represent 95% confidence intervals.
Received 18 April 2005, accepted 20 May 2006
Abstract
Objective: To assess the efficacy of endovenous laser therapy (EVLT) for treating varicose veins with saphenous reflux.
Design: A trial of treatment, with results assessed by ultrasound surveillance.
Setting: Outpatient clinics with sonographer and nursing support.
Main outcome measures: Control of reflux; occlusion or obliteration of the saphenous veins assessed by ultrasound.
Results: EVLT was used to treat 404 veins in 308 patients. Univariate life table analysis showed primary success in 80% (95% CI, 69%–87%) and secondary success after further treatment of recurrent saphenous vein reflux by ultrasound-guided sclerotherapy in 88% (95% CI, 78%–95%) at 3 years. On multivariate Cox regression analysis, none of the covariates studied were associated with ultrasound failure.
Conclusions: Early results indicate that EVLT effectively controlled saphenous reflux. Its advantages are that it is performed as an outpatient procedure under local anaesthesia with immediate mobilisation, causes minimal disruption of activities, and avoids surgical trauma.